Why is Biofil Chemicals falling/rising?

As of 07-Oct, Biofil Chemicals & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 40.50, which reflects a decrease of Rs. 0.63 or 1.53%. The stock has hit a new 52-week low of Rs. 40.21 today and has underperformed its sector by 1.84%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The recent performance metrics show that the stock has declined by 3.30% over the past week and 3.59% over the past month, while year-to-date it has fallen by 28.95%. There is a notable drop in investor participation, with delivery volume on October 6 falling by 77.69% compared to the 5-day average, suggesting a lack of interest among investors.
In the broader market context, the Sensex has shown a positive return of 2.07% over the past week and 1.51% over the past month, contrasting sharply with Biofil's negative performance. This divergence indicates that while the overall market is gaining, Biofil Chemicals is struggling significantly. The stock's year-over-year decline of 42.23% further emphasizes its underperformance relative to the benchmark, which has only increased by 1.08% in the same period. The lack of available positive factors in the dashboard suggests that there are no recent developments to counterbalance the negative trends affecting the stock, contributing to its continued decline.